Literature DB >> 6170067

Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli.

P MacKay, M Pasek, M Magazin, R T Kovacic, B Allet, S Stahl, W Gilbert, H Schaller, S A Bruce, K Murray.   

Abstract

Several plasmids have been constructed which direct the synthesis of hepatitis B virus surface antigens in Escherichia coli either as the native polypeptide or fused to other plasmid encoded polypeptides. When injected into rabbits, extracts from bacteria carrying some of these plasmids induced the synthesis of antibodies to the antigens even though the extracts did not give satisfactory positive results in radioimmunoassay for them. Either the NH2-terminal segment or the COOH-terminal segment of the surface antigens alone was sufficient to elicit the immune response, but antibodies against the two segments showed different specificities. The results emphasize the value of an in vivo assay for the presence of antigens in crude cell extracts and illustrate the feasibility of this type of screening with laboratory animals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170067      PMCID: PMC319821          DOI: 10.1073/pnas.78.7.4510

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Immunochemistry of hepatitis B surface antigen (HBsAg): preparation and characterization of antibodies to the constituent polypeptides.

Authors:  J W Shih; J L Gerin
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

2.  Sialyl residues in hepatitis B antigen: their role in determining the life span of the antigen in serum and in eliciting an immunological response.

Authors:  A R Neurath; N Hashimoto; A M Prince
Journal:  J Gen Virol       Date:  1975-04       Impact factor: 3.891

3.  Immunological screening method to detect specific translation products.

Authors:  S Broome; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

7.  Mucopeptide biosynthesis by minicells of Escherichia coli.

Authors:  J N Reeve
Journal:  J Bacteriol       Date:  1977-07       Impact factor: 3.490

8.  Microtiter solid-phase radioimmunoassay for hepatitis B antigen.

Authors:  R H Purcell; D C Wong; H J Alter; P V Holland
Journal:  Appl Microbiol       Date:  1973-10

9.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  Bacteriophage infection of minicells: a general method for identification of "in vivo" bacteriophage directed polypeptide biosynthesis.

Authors:  J N Reeve
Journal:  Mol Gen Genet       Date:  1977-12-14
View more
  12 in total

1.  Immunogenicity of peptide fusions to hepatitis B virus core antigen.

Authors:  S J Stahl; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Fusion polypeptides in gene cloning: potential problems due to conformational alterations at the junction.

Authors:  E Querol; A Parrilla
Journal:  Experientia       Date:  1987-08-15

3.  Direct expression of hepatitis B surface antigen gene in E. coli.

Authors:  Y Fujisawa; Y Ito; R Sasada; Y Ono; K Igarashi; R Marumoto; M Kikuchi; Y Sugino
Journal:  Nucleic Acids Res       Date:  1983-06-11       Impact factor: 16.971

4.  A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice.

Authors:  M Singh; R Cattaneo; M A Billeter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted diseases.

Authors:  B J Cohen; P A Litton; P P Mortimer; P Simmons
Journal:  J Hyg (Lond)       Date:  1984-10

6.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.

Authors:  J L Gerin; H Alexander; J W Shih; R H Purcell; G Dapolito; R Engle; N Green; J G Sutcliffe; T M Shinnick; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

8.  Expression of Plasmodium falciparum surface antigens in Escherichia coli.

Authors:  F Ardeshir; J E Flint; R T Reese
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Hepatitis B virus antigens made in microbial cells immunise against viral infection.

Authors:  K Murray; S A Bruce; A Hinnen; P Wingfield; P M van Erd; A de Reus; H Schellekens
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  Identification of a cDNA clone encoding a mature blood stage antigen of Plasmodium falciparum by immunization of mice with bacterial lysates.

Authors:  R L Coppel; G V Brown; G F Mitchell; R F Anders; D J Kemp
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.